Precision Palliative Care for Patients With Advanced Esophageal Cancer
NCT06787313 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 624
Last updated 2026-01-13
Summary
The goal of this clinical trial is to learn if precision palliative care improves survival of patients with advanced esophageal cancer in adults.
Researchers will compare precision palliative care and standard palliative care to see if precision palliative care works more effectively to treat advanced esophageal s cancer.
Participants will receive precision palliative care or standard palliative care. All participants will answer survey questions about their quality of life, MDASI, PHQ-9, GAD-7 for 1 years.
Conditions
- Esophageal Cancer
Interventions
- OTHER
-
precision palliative care
Participants receive precision palliative care based on scale screening result.
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-31
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- China
Study Locations
More Related Trials
-
Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
NCT03904927 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT02384811 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
NCT02325986 ·Status: UNKNOWN ·Phase: PHASE2
-
Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy
NCT07164690 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT03286920 ·Status: UNKNOWN
-
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma
NCT01591135 ·Status: COMPLETED ·Phase: PHASE3
-
Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 Inhibitor
NCT06190782 ·Status: RECRUITING ·Phase: PHASE3
-
Study of S-1 in Combination With Radiotherapy in Esophageal Cancer
NCT01831531 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
NCT00021320 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
NCT01216527 ·Status: UNKNOWN ·Phase: PHASE3
-
Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
NCT02556762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Chemoradiotherapy in Unresectable Esophageal Cancer
NCT04278287 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer
NCT02459457 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Patients With Esophageal Cancer
NCT00041262 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiation Dose Escalation in Esophageal Cancer
NCT03082586 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
NCT06401447 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
NCT04137679 ·Status: UNKNOWN ·Phase: PHASE2
-
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
NCT02813967 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
NCT02916511 ·Status: COMPLETED ·Phase: PHASE2
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA
-
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002884 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
NCT04196075 ·Status: COMPLETED ·Phase: PHASE3